| |
|
Form Serial Number: |
CS20260623E00040 |
| 1.
Date of relevant event: |
18/06/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02607 |
| 4.
Name of listed corporation: |
Shanghai Pharmaceuticals Holding Co., Ltd. - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
919,072,704 |
| 7.
Name of substantial shareholder: |
Shanghai Shangshi (Group) Co., Ltd. 上海上實(集團)有限公司 |
| 8.
Registered office: |
上海市淮海中路98號金鐘廣場21樓 |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
N/A |
| 16.
Name of listed parent and exchange on which parent is listed: |
N/A |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1113 | The percentage level of your interest in the shares has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
1,200,000 |
HKD |
12.0200 |
11.9300 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 366,958,000 | 39.93 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 368,158,000 | 40.06 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Golden Bell International Holdings Limited 金鐘國際控股有限公司 | 27/F, Harcourt House, 39 Gloucester Road, Wan Chai, Hong Kong | Shanghai Shangshi (Group) Co., Ltd. 上海上實(集團)有限公司 | 100.00 | N | |
| Shanghai Industrial Investment (Holdings) Company Limited 上海實業(集團)有限公司 | 27/F., Harcourt House, 39 Gloucester Road, Wanchai, Hong Kong | Golden Bell International Holdings Limited 金鐘國際控股有限公司 | 100.00 | N | |
| SIIC International Investment Company Limited 上實國際投資有限公司 | 27/F., Harcourt House, 39 Gloucester Road, Wanchai, Hong Kong | Shanghai Industrial Investment (Holdings) Company Limited 上海實業(集團)有限公司 | 100.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
On 18 June 2026, SIIC International Investment Company Limited, an indirectly wholly owned subsidiary of Shanghai Shangshi (Group) Co., Ltd., purchased 1,200,000 H shares of Shanghai Pharmaceuticals Holding Co., Ltd., resulting in an increase crossing over a whole percentage number in the shareholding percentage figure of the deemed interests of Shanghai Shangshi (Group) Co., Ltd.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
23/06/2026
(dd/mm/yyyy)
|
|
|
|
|